Parkman Healthcare Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2M | Buy |
1,298,825
+234,319
| +22% | +$3.28M | 2.09% | 16 |
|
|
2025
Q1 | $14.3M | Sell |
1,064,506
-23,128
| -2% | -$312K | 1.7% | 24 |
|
|
2024
Q4 | $20.8M | Buy |
1,087,634
+662,634
| +156% | +$12.7M | 2.78% | 8 |
|
|
2024
Q3 | $9.67M | Buy |
+425,000
| New | +$9.67M | 1.23% | 29 |
|
|
2022
Q4 | – | Sell |
-35,358
| Closed | -$725K | – | 94 |
|
|
2022
Q3 | $725K | Buy |
+35,358
| New | +$725K | 0.21% | 80 |
|